Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone nasal ointment in rhinosinusitis
2004-005074-24Phase 4Active
- Sponsor
- Febena Pharma
- Start
- Sep 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in rhinosinusitis and allergic rhinitis (AR) (2 arms), sponsored by Febena Pharma. Primary endpoint: Baseline-adjusted AUC of Total Combined Score (TCS) days 5–9. Started Sep 2005; status: active.
02
Drugs
dexamethasone
03
Conditions
rhinosinusitisallergic rhinitis (AR)
Beyond the preview
Go deeper on 2004-005074-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005074-24.